On December 28, 2023, Jeff Castelli, Chief Development Officer of Amicus Therapeutics Inc (NASDAQ:FOLD), sold 17,421 shares of the company's stock, according to a recent SEC Filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
On December 28, 2023, Jeff Castelli, Chief Development Officer of Amicus Therapeutics Inc (NASDAQ:FOLD), sold 17,421 shares of the company's stock, according to a recent SEC Filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles